Efficacy and safety of MYL-1501D versus insulin glargine in patients with type 2 diabetes after 24 weeks: Results of the phase III INSTRIDE 2 study

Thomas C. Blevins, Abhijit Barve, Bin Sun, Yaron Raiter, Patrick Aubonnet, Rafael Muniz, Sandeep Athalye, Michael Ankersen
  • Diabetes Obesity and Metabolism, September 2018, Wiley
  • DOI: 10.1111/dom.13495

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1111/dom.13495

In partnership with: